Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
about
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@ast
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@en
type
label
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@ast
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@en
prefLabel
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@ast
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@en
P2093
P2860
P1476
Cost-effectiveness of adding n ...... istant tuberculosis in Germany
@en
P2093
Daniel Wirth
Ramesh Dass
Robert Hettle
P2860
P2888
P356
10.1186/S12913-017-2118-2
P577
2017-03-08T00:00:00Z
P6179
1084250973